CERBA - 2Q16 Results: All signals on green
​Like Synlab and Unilabs earlier this week, Cerba, France’s No.1 clinical test laboratory, reported strong 2Q16 results. The company, which derives 80% of its revenues from France, rode on a buoyant local market. What’s more, the 2015 acquisition of Novescia, which strengthened Cerba’s leadership of the routine segment, seems well digested, allowing it to focus on topline
Spread Research is France's first Rating Agency, registered by ESMA (European Securities and Markets Authority) and a leading European Independent Credit Research firm, founded in 2004 and based in Lyon, France. Our experienced team offer key research services using a wide range of investment strategies and research methodologies for the High Yield, Emerging Markets, Convertibles and Loan Markets.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.